Ear device could tame dangerous brain injury symptoms in kids
NCT ID NCT05343988
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a small device placed on the ear that sends gentle electrical pulses to calm overactive nerves in children with severe brain injury. The goal was to reduce sudden episodes of fast heart rate, high blood pressure, and other symptoms. The trial was very small and was stopped early, so we don't yet know if it works.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Percutaneous Electrical Nerve Field Stimulation (PENFS) device
- What this could lead to
- If it works, this could offer a non-drug way to reduce dangerous symptoms like rapid heart rate and high blood pressure in children with severe brain injury.
- What could go wrong
- This was a very small pilot study (20 children) that was terminated early, so results are limited. The device is still experimental and may not work for all children.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
20 people
The number who actually took part.
- Started
-
Sep 2022
- Finished
-
Nov 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
2 to 17 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Children 2-17 years age with PSH due to ASBI * PSH severity score \> 6 (moderate severity) * Glasgow Coma Scale \< 15 Exclusion Criteria: * age \< 2 years (small ears thus less surface area to apply the leads) * ear deformity or severe dermatitis of ear lobes, * intractable seizures, heart block, patients with other implantable devices (cardiac pacemaker, vagal nerve stimulator, etc. * known pregnancy
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Paroxysmal sympathetic hyperactivity are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Children's Wisconsin
Milwaukee, Wisconsin, 53226, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.